Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000908834-24-000173
Filing Date
2024-06-18
Accepted
2024-06-18 16:15:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 aktx_13d.htm SC 13D 70014
2 image0.jpg GRAPHIC 1147
  Complete submission text file 0000908834-24-000173.txt   73235
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: SC 13D | Act: 34 | File No.: 005-87614 | Film No.: 241051966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 VILLAGE SQUARE XING SUITE 102 PALM BEACH FL 33410
Business Address
Theofilos Charles Steve (Filed by) CIK: 0002003243 (see all company filings)

Type: SC 13D